Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Acq. announced
Director departure
Appointed director
|
|
SELLAS Life Sciences Group, Inc. (SLS)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/16/2022 |
3
| Kalin Katherine Bach (Director) has filed a Form 3 on SELLAS Life Sciences Group, Inc. |
| 03/14/2022 |
3
| Francomano Robert (Chief Commercial Officer) has filed a Form 3 on SELLAS Life Sciences Group, Inc. |
| 12/19/2018 |
3
| Burns John Thomas (VP, Finance & Corp Controller) has filed a Form 3 on SELLAS Life Sciences Group, Inc. |
| 04/24/2018 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/16/2018 |
3
| WOOD BARBARA A (EVP, Gen. Counsel, Corp. Sec.) has filed a Form 3 on SELLAS Life Sciences Group, Inc. |
| 12/29/2017 |
3
| Wasman Jane (Director) has filed a Form 3 on SELLAS Life Sciences Group, Inc. |
| 12/29/2017 |
3
| Varian John (Director) has filed a Form 3 on SELLAS Life Sciences Group, Inc. |
| 12/29/2017 |
3
| VAN NOSTRAND ROBERT L (Director) has filed a Form 3 on SELLAS Life Sciences Group, Inc. |
| 12/29/2017 |
3
| SCHEINBERG DAVID A (Director) has filed a Form 3 on SELLAS Life Sciences Group, Inc. |
| 12/29/2017 |
3
| Lopez Fabio (10% Owner) has filed a Form 3 on SELLAS Life Sciences Group, Inc. |
| 12/29/2017 |
3
| Torre Gregory M (CRO and SVP) has filed a Form 3 on SELLAS Life Sciences Group, Inc. |
| 12/29/2017 |
3
| Sarlis Nicholas J. (Chief Medical Officer and SVP) has filed a Form 3 on SELLAS Life Sciences Group, Inc. |
| 12/29/2017 |
3
| Krylov Aleksey N. (Interim CFO) has filed a Form 3 on SELLAS Life Sciences Group, Inc. |
| 12/29/2017 |
3
| Stergiou Andelos M. (President and CEO) has filed a Form 3 on SELLAS Life Sciences Group, Inc. |
| 02/10/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 11/15/2016 |
3
| Ghiglieri Stephen F (CFO) has filed a Form 3 on Galena Biopharma, Inc. |
| 04/28/2016 |
3
| GRAY MARY ANN (Director) has filed a Form 3 on Galena Biopharma, Inc. |
| 03/01/2013 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 07/25/2012 |
3
| Dunlap Ryan (Principal Accounting Officer) has filed a Form 3 on Galena Biopharma, Inc. |
| 04/17/2012 |
3
| MAZANET ROSEMARY (Chief Medical Officer) has filed a Form 3 on Galena Biopharma, Inc. |
| 10/27/2011 |
3
| Lee Kwang (Principal Accounting Officer) has filed a Form 3 on Galena Biopharma, Inc. |
| 04/21/2011 |
3
| SCHWARTZ MARK W. (EVP COO) has filed a Form 3 on RXI PHARMACEUTICALS CORP |
| 04/21/2011 |
3
| Kennedy Robert Eugene (Vice President and CFO) has filed a Form 3 on RXI PHARMACEUTICALS CORP |
| 11/09/2009 |
3
| Beerman Noah D (CEO and President) has filed a Form 3 on RXI PHARMACEUTICALS CORP |
| 09/10/2009 |
3
| Tata Amy B (Director of Accounting) has filed a Form 3 on RXI PHARMACEUTICALS CORP |
| 04/27/2009 |
3
| Chin Richard (Director) has filed a Form 3 on RXI PHARMACEUTICALS CORP |
| 03/31/2009 |
3
| Varanasi Ramani (VP, Business Development) has filed a Form 3 on RXI PHARMACEUTICALS CORP |
|
|